Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: OECD protocl study under GLP; no deviations

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1991
Report date:
1991

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
GLP compliance:
yes (incl. QA statement)
Type of assay:
micronucleus assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Sodium 2-methylprop-2-ene-1-sulphonate
EC Number:
216-341-5
EC Name:
Sodium 2-methylprop-2-ene-1-sulphonate
Cas Number:
1561-92-8
Molecular formula:
C4H8O3S.Na
IUPAC Name:
sodium 2-methylprop-2-ene-1-sulfonate
Test material form:
solid: crystalline
Details on test material:
- Name of test material (as cited in study report): natriummethallylsulfonat
- Substance type: organic
- Physical state: solid crystalline
- Analytical purity: 99.8 %
- Impurities (identity and concentrations):
- Composition of test material, percentage of components: < 0.2% water. 0.05% naCl
- Isomers composition:
- Purity test date: Oct 1989
- Lot/batch No.: unknown
- Expiration date of the lot/batch: undeterminate
- Stability under test conditions: stable
- Storage condition of test material: Normal lab conditions

Test animals

Species:
mouse
Strain:
other: BOR:NMRI (SPF Harlan)
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Fa Winkelmann, 4799 Borchem , Germany
- Age at study initiation: young adult mice
- Weight at study initiation: male 23.3 +- 0.9 ; female 23.5 +- 0.7
- Assigned to test groups randomly: [no/yes, under following basis: ] yes
- Fasting period before study: 18 hrs
- Housing: sex-separated, 5 anmials / Makrolon cage type III
- Diet (e.g. ad libitum): Saniff R10, Fa. Sniff 4770, Soest
- Water (e.g. ad libitum): ad lib
- Acclimation period: 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 C +-1
- Humidity (%): 60 %+- 10
- Air changes (per hr):
- Photoperiod (hrs dark / hrs light): 12/12

IN-LIFE DATES: within lab: from 19-04-1990 to 28-09-1990

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
aqua bidest
Details on exposure:
PREPARATION OF DOSING SOLUTIONS:

Duration of treatment / exposure:
24, 48 and 72 hrs
Frequency of treatment:
single dose
Post exposure period:
None
Doses / concentrationsopen allclose all
Remarks:
Doses / Concentrations:
1250 mg/kg bw
Basis:
actual ingested
dose determined on the basis of body weight immediately prior to dosing
Remarks:
Doses / Concentrations:
2500 mg/kg bw
Basis:
actual ingested
dose determined on the basis of body weight immediately prior to dosing
Remarks:
Doses / Concentrations:
5000 mg/kg bw
Basis:
actual ingested
dose determined on the basis of body weight immediately prior to dosing
No. of animals per sex per dose:
5 / 5
Control animals:
yes
yes, concurrent vehicle
Positive control(s):
cyclophosphamide;
- Justification for choice of positive control(s): Known positive, historical data available
- Route of administration: oral gavage
- Doses / concentrations: 100 mg/kg bw

Examinations

Tissues and cell types examined:
1000 polychromatic erythrocytes / animal
Details of tissue and slide preparation:
CRITERIA FOR DOSE SELECTION: dose-range finding with 5000, 6500, 7500 and 10000 mg/kg bw established confirmed highest LD (zero) of 5000 mg/kg bw


TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
after preparation of both femurs, the bone marrow is washed out using fetal bovine serum and a syringe. the cell suspension was centrifuged for 5 minutes at 160 g, then decanted and re-suspended. This suspension was cleaned by means of a cellulose chromatography tube.
The eluate from the tube was centrifuged (10 min/800 g) , the pellet was re-suspended in fetal bovine serum with 25mM EDTA.
DETAILS OF SLIDE PREPARATION:
From this suspension, 3-4 slides were prepared, dried for 24 hrs and colored with May-Gruenwald / Giemsa solution

METHOD OF ANALYSIS:
100-fold enlargement, Zeiss Microscope
1000 PCE cells/. animals
number of PCE cells with micronuclei
PCE /NCE determined
number of NCE cells with micronuclei .

Evaluation criteria:
Positive if a statistically significant increase in the frequency of micronucleus-containing PCE is found in at least one test group relatie to the neagative controls
Statistics:
Not specified

Results and discussion

Test results
Sex:
male
Genotoxicity:
negative
Toxicity:
yes
Remarks:
discolored feces (all animals and mild diarrhea in males
Vehicle controls validity:
valid
Negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
RESULTS OF RANGE-FINDING STUDY
- Dose range: 500, 6500, 7500, 10000 mg/kg bw
- Solubility: 750 g/l
- Clinical signs of toxicity in test animals: sedation and 1/3 fatality in 6500 group, sedation and 1 / 5 fatalties in teh 7500 group, sedation and 3/ /5 fatalities in the 10000 group.
- Harvest times: 24, 48, 72 hrs

RESULTS OF DEFINITIVE STUDY


- Induction of micronuclei (for Micronucleus assay): see table
- Ratio of PCE/NCE (for Micronucleus assay): see tabel
- Appropriateness of dose levels and route: route is appropriate in view of exposure potential; dose: you can't go much higher, can you?.
- Statistical evaluation: see table.

Any other information on results incl. tables

Testgruppe

Dosis

Entnahme nach

% PCE mit

PCE/NCE

 

(mg/kg KG)

Appl. (in h)

MK (x ± SD)

(x ± SD)

Positivkontrolle

 

 

 

 

(Cyclophosphamid)

100

24

* 3,95 ± 1,37

* 0,48 ± 0,2

 

_

24

0,07 ± 0,05

1,13 ± 0,2

Negativkontrolle

 

 

 

 

(Wasser)

-

48

0,25 ± 0,12

1,31 ± 0,09

 

-

72

0,28 ± 0,10

1,20 ± 0,33

 

5000

24

0,09 ± 0,06

0,97 ± 0,2

NATRIUM­

 

 

 

 

METHALLYL­

5000

48

0,18 ± 0,08

1,26 ± 0,16

SULFONAT

 

 

 

 

(Gruppe I)

5000

72

0,18 ± 0,11

1,38 ± 0,20

MAS-Na (Gruppe II)

2500

24

0,13 ± 0,06

1,10 ± 0,3

MAS-Na (Gruppe III)

1250

24

0,05 ± 0,05

1,20 ± 0,2

* statistisch signifikante Veranderung gegenüber der Negativkontrolle (Vertrauensbereich = 95 %)


Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): negative No significant increase in frequency of miconuclei
Substance is not clastogenic in a mouse micronucleas test at dose levels of 1250, 2500 and 5000 mg/kg bw.
Executive summary:

Substance was tested in a mouse bone marrow micronucleus test according to OECD 474.

Substance is not clastogenic in this test at dose levels of 1250, 2500 and 5000 mg/kg bw.